Baxter Split Should Unlock Healthy Gains Barron's s Joshua Jennings noted last week, experts from the firm's health-care conference believe there is a "strong appetite" for these drugs, and while "first-to-market opportunities will have advantages, they think there is room for multiple agents in this ... |
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment